Astrana Health (ASTH) Gains from Sales and Divestitures (2024 - 2025)
Astrana Health's (ASTH) quarterly Gains from Sales and Divestitures came in at $363061.0 in Q4 2025, up 364.24% year-on-year from $78206.0 in Q4 2024, and up 364.24% quarter-over-quarter from $78206.0 in Q4 2024.
Astrana Health (ASTH) Gains from Sales and Divestitures (2024 - 2025) Analysis & Trends
Astrana Health has disclosed Gains from Sales and Divestitures across 2 years of filings, most recently posting $363061.0 for Q4 2025.
- Gains from Sales and Divestitures for Q4 2025 came in at $363061.0, up 364.24% year-over-year; the trailing twelve-month figure through Dec 2025 was $363061.0 (up 364.24% YoY), and the FY2025 annual result was $363061.0, up 364.24% from the prior year.
- Gains from Sales and Divestitures came in at $363061.0 for Q4 2025 at Astrana Health, up from $78206.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $363061.0 in Q4 2025 to a low of $78206.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn |
| 10 | Astrana Health | 1.92 Bn | 1.45 Bn | 105.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 363,061.00 |
| Dec 31, 2025 | 363,061.00 |
| Dec 31, 2024 | 78,206.00 |
| Dec 31, 2024 | 78,206.00 |